Rigel Pharmaceuticals Inc —— 季度财务数据 (NASDAQ:RIGL) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 14.5 M-893 K30.54 M24.03 M21.98 M 75.66 M 投资活动产生的现金 -10.91 M-10.55 M-23.28 M-33.17 M-25.36 M -92.36 M 融资活动产生的现金 1.47 M484 K418 K4.27 M-4.57 M 601 K 自由现金流 14.5 M-893 K30.54 M24.03 M21.98 M 75.66 M

新闻

Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (NASDAQ:RIGL)

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Micron and Coinbase among market cap stock movers on Wednesday

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript

Rigel 2025年第四季度业绩:年增长60%,MDS数据前景看好

Rigel Q4 2025 slides: 60% annual growth, promising MDS data

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates

X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval

Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan

Implied Volatility Surging for Rigel Pharmaceuticals Stock Options

Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline

Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates